AMGN · Amgen Inc.

Summary

Amgen Inc. issued and sold $1,000,000,000 aggregate principal amount of securities on February 17, 2026, entering into a material definitive agreement evidenced by an Underwriting Agreement with BofA Securities. The filing includes Exhibit 1.1 detailing the agreement.

Key takeaways

• Issued and sold $1,000,000,000 aggregate principal amount on February 17, 2026
• Entered into Underwriting Agreement dated February 17, 2026
• Counterparties include BofA Securities
• Filed as Item 1.01 Material Definitive Agreement
• Exhibit 1.1: Underwriting Agreement